Zydus Therapeutics announces positive phase 2b / 3 results for Saroglitazar
The company has got encouraging topline results from its pivotal EPICS- III Phase 2b / 3 clinical trial of adult patients with Primary Biliary Cholangitis.
Eli Lilly and Company’ s oral GLP-1 Orforglipron clears third Phase 3 trial
It has announced positive topline results from the Phase 3 ATTAIN-2 trial of adults with obesity or overweight and type 2 diabetes.
New flu vaccine guidelines put spotlight on India’ s low coverage
Zydus Lifesciences organised a health symposium in Bengaluru to discuss the transition to the new influenza vaccination guidelines recommended by WHO.
BioTech
Takeda India launches‘ For You, With You IBD’ app
The mobile application is designed to support individuals having Inflammatory Bowel Disease( IBD), aimed at supporting everyday disease management and well-being.
BIOVOICENEWS. COM 09